Microcystins (MCs), a toxin produced by some species of the photosynthetic autotrophic cyanobacteria, are the most studied and monitored cyanotoxin in water. Water treatment plant (WTP) residuals are the byproduct of water treatment consisting of solids removed from WTP processes and have been shown to contain cyanobacterial cells. However, the presence of MCs in WTP residuals has not been systematically demonstrated. Samples from four different WTPs across the United States were used to quantify MCs in residuals while assessing extraction and quantification methods adapted from water samples for solid matrices. MCs were present in 100% of samples. MC-LA was the most prevalent variant in these samples (70.05% of MCs quantified by UPLC-PDA). Natural degradation observed in a WTP storage lagoon was also investigated to determine the impact of physical, chemical, and biological processes on MC concentrations in high-biomass residuals. This study demonstrates that residuals of various characteristics across the United States contain MCs, and no one method was found to maximize results consistently across all samples. Cyanotoxins accumulating in WTP residuals are a growing concern. Implications of this work can help regulations and future studies of potential reuse applications and understanding of potential ecological significance of MCs accumulating in WTP residuals.

Download full-text PDF

Source
http://dx.doi.org/10.1080/09593330.2024.2402098DOI Listing

Publication Analysis

Top Keywords

wtp residuals
16
water treatment
12
treatment plant
8
residuals
8
extraction quantification
8
united states
8
accumulating wtp
8
mcs
7
wtp
6
samples
5

Similar Publications

Microcystins (MCs), a toxin produced by some species of the photosynthetic autotrophic cyanobacteria, are the most studied and monitored cyanotoxin in water. Water treatment plant (WTP) residuals are the byproduct of water treatment consisting of solids removed from WTP processes and have been shown to contain cyanobacterial cells. However, the presence of MCs in WTP residuals has not been systematically demonstrated.

View Article and Find Full Text PDF

Aims: Mosunetuzumab has received accelerated approval by the US Food and Drug Administration for adult patients with relapsed or refractory (R/R) follicular lymphoma (FL) after two or more lines of systemic therapy. We evaluated the cost-effectiveness of mosunetuzumab for the treatment of R/R FL from a US private payer perspective.

Materials And Methods: A partitioned survival model simulated lifetime costs and outcomes of mosunetuzumab against seven comparators: axicabtagene ciloleucel (axi-cel), tisagenlecleucel (tisa-cel), tazemetostat (taz, EZH2 wild-type only), rituximab plus lenalidomide (R-Len) or bendamustine (R-Benda), obinutuzumab plus bendamustine (O-Benda), and a retrospective real-world cohort (RW) based on current patterns of care derived from US electronic health records (Flatiron Health).

View Article and Find Full Text PDF

Objective: To compare the cost-effectiveness of serial non-echo planar diffusion weighted MRI (non-EP DW MRI) versus planned second look surgery following initial canal wall up tympanomastoidectomy for the treatment of cholesteatoma.

Methods: A decision-analytic model was developed. Model inputs including residual cholesteatoma rates, rates of non-EP DW MRI positivity after surgery, and health utility scores were abstracted from published literature.

View Article and Find Full Text PDF

Cost-utility analysis of adjunct repetitive transcranial magnetic stimulation for treatment resistant bipolar depression.

J Affect Disord

July 2024

School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia; Institute for Health Transformation, Deakin University, Geelong, Australia.

Objective: To evaluate the cost-effectiveness of repetitive transcranial magnetic stimulation (rTMS) as an adjunct to standard care from an Australian health sector perspective, compared to standard care alone for adults with treatment-resistant bipolar depression (TRBD).

Methods: An economic model was developed to estimate the cost per disability-adjusted life-year (DALY) averted and quality-adjusted life-year (QALY) gained for rTMS added to standard care compared to standard care alone, for adults with TRBD. The model simulated the time in three health states (mania, depression, residual) over one year.

View Article and Find Full Text PDF

Aim: The aim of this in vitro study was to investigate the influence of scan paths on the accuracy (trueness and precision) of intra-oral scanning of an implant impression on an edentulous patient.

Material And Methods: An epoxy resin maxillary model was made with 6 bone level implants (NobelParallel Conical Connection RP, NobelBiocare®). The implants were placed at the spot of the first incisor, the canine and the first molar.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!